A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer

[1]  Y. Ko,et al.  A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors. , 2007, International journal of radiation oncology, biology, physics.

[2]  E. Rakovitch,et al.  Whole brain radiotherapy for the treatment of multiple brain metastases. , 2006, The Cochrane database of systematic reviews.

[3]  A. Grosu,et al.  Integration of chemotherapy into current treatment strategies for brain metastases from solid tumors , 2006, Radiation oncology.

[4]  D. Stewart.  Update on the role of topotecan in the treatment of non-small cell lung cancer. , 2004, The oncologist.

[5]  M. Millward,et al.  A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. , 2004, Lung cancer.

[6]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[7]  A. Minagar,et al.  Gamma knife surgery in the management of brain metastases from lung carcinoma: a retrospective analysis of survival, local tumor control, and freedom from new brain metastasis. , 2004, Journal of neurosurgery.

[8]  E. Wong,et al.  The role of topotecan in the treatment of brain metastases. , 2004, The oncologist.

[9]  A. Hauschild,et al.  A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma , 2003, Melanoma research.

[10]  E. Thiel,et al.  Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. a multicentre phase II study. , 2002, European journal of cancer.

[11]  D. Antonadou,et al.  Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  T Sahmoud,et al.  Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Levendag,et al.  Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. , 1999, International journal of radiation oncology, biology, physics.

[14]  J. Carmichael,et al.  Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Mehta,et al.  The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation , 1996, Journal of Neuro-Oncology.

[16]  S. Baker,et al.  Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors , 1995, Cancer Chemotherapy and Pharmacology.

[17]  F. Balis,et al.  A pharmacokinetic model of topotecan clearance from plasma and cerebrospinal fluid. , 1994, Cancer research.

[18]  H. Mogami,et al.  Chemotherapy of brain metastases from lung carcinoma: a controlled randomized study. , 1991, Neurosurgery.

[19]  Y Maruyama,et al.  A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.

[20]  G. Wampler,et al.  Intracerebral metastases in solid‐tumor patients: Natural history and results of treatment , 1981, Cancer.

[21]  P. O'Brien,et al.  A multiple testing procedure for clinical trials. , 1979, Biometrics.

[22]  S. Pocock,et al.  Size of cancer clinical trials and stopping rules. , 1978, British Journal of Cancer.

[23]  H. Eich,et al.  Phase I/II Trial of Simultaneous Whole-Brain Irradiation and Dose-Escalating Topotecan for Brain Metastases , 2005, Strahlentherapie und Onkologie.

[24]  N. Viñolas,et al.  Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. , 2005, International journal of radiation oncology, biology, physics.

[25]  T. Lesimplef,et al.  A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma , 2003 .

[26]  R. Fietkau,et al.  Phase I/II clinical trial of concurrent radiochemotherapy in combination with topotecan for the treatment of brain metastases. , 2002, European journal of cancer.

[27]  A. Brioschi,et al.  Pathophysiology, clinical manifestations and supportive care of metastatic brain cancer. , 2001, Forum.

[28]  L. Thiberville,et al.  Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  J. von Pawel,et al.  Topotecan--a new treatment option in the therapy of brain metastases of lung cancer. , 1999, Frontiers of radiation therapy and oncology.

[30]  H. Minn,et al.  Prognosis of patients treated for intracranial metastases with whole-brain irradiation. , 1998, Annals of medicine.

[31]  Postmus.  Brain Metastases From Small Cell Lung Cancer: Chemotherapy, Radiotherapy, or Both? , 1995, Seminars in radiation oncology.

[32]  S. Kim,et al.  Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I. , 1992, International journal of radiation oncology, biology, physics.

[33]  Roy A. Patcheil.  Brain metastases. , 1991, Neurologic clinics.